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Background
The G protein-coupled receptor 55 (GPR55) has recently
been suggested to be responsible for those cannabinoid
responses that could not be attributed to either the canna-
binoid 1 (CB1) or cannabinoid 2 (CB2) receptor. Several
potent GPR55 agonists were identified such as lysopho-
sphatidylinositol (LPI) and several synthetic cannabinoids:
One of these is rimonabant (SR141716A), an antagonist at
the CB1 receptor, which showed clinical promise, but
approval was revoked due to adverse events. Generally, the
activity of G protein coupled receptors (GPCRs) is coordi-
nated by receptor signalling, receptor desensitization and
receptor resensitization. One regulatory mechanism to
guarantee appropriate GPCR expression levels in physiolo-
gical conditions is that of downregulating GPCRs via the
G protein-coupled receptor-associated sorting protein 1
(GASP-1), thus leading to an attenuation of cellular signal-
ling events. GASP-1 was originally found to target δ opioid
receptors to lysosomes and, hence, to the degradative
pathway. It was shown that GASP-1 is a key determinant
in the development of analgesic tolerance to cannabinoids
via its role in facilitating downregulation of the CB1
receptor.
Methods and results
By a variety of approaches we demonstrated that rimona-
bant promotes downregulation of GPR55 via GASP-1 in
vitro and in vivo. We show that GPR55 interacts with
GASP-1 in vitro and that disrupting the GPR55/GASP-1
interaction prevents post-endocytic receptor degradation,
and thereby allows receptor recycling. Together, these
data implicate GASP-1 as an important regulator of
rimonabant-mediated downregulation of GPR55.
Conclusions
This work provides tangible evidence that GPR55 is
degraded after prolonged agonist stimulation and that
this mechanism is regulated by GASP-1.
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